VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Key genetic changes that elicit the transformation of plasma cells in myeloma

Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses key genetic changes that elicit the transformation of plasma cells and influence disease progression in multiple myeloma, and the importance of further investigating these processes. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter